Marking a first for the iconic brand, Eucerin Face is rolling out in Target doors now, Beiersdorf leaders noted in a 7 August half-year earnings presentation. The firm’s Consumer business segment recorded nominal sales growth of 5.4% to €4.3bn in the first half of 2024, led by Nivea.
Beiersdorf AG’s major dermatological initiatives in the US over the next six months include the first Eucerin Face range in Target doors, the early 2025 debut of an anti-pigment ingredient that is already propelling growth abroad, and a major relaunch of Nivea Body.
Eucerin Face rolled out to a limited number of CVS doors as well as Amazon at the end of the...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
